Marco Trucco (2022) “Two Cases of New Daily Persistent Headache Successfully Treated with Onabotulinum Toxin Type A (BoNT-A)”, Current Innovations in Medicine and Medical Science Vol. 7, pp. 169–178. doi: 10.9734/bpi/cimms/v7/4654A.